Subscribe to Newsletter

Discovery & Development

Discovery & Development Drug Discovery

Addressing the Empire of Pain

| Jamie Irvine | 11 min read

How the pharma industry can help tackle the opioid crisis and advance treatments

Discovery & Development Drug Delivery

The Changing Face of Influenza Vaccination

| Rob Coker

Flu changes, ever so slightly, year by year and region by region. The vaccine manufacturing industry must bring changes of its own.

Discovery & Development Advanced Medicine

Victor Ambros and Gary Ruvkun share 2024 Nobel Prize for Physiology or Medicine

| Rob Coker

The Nobel Prize for Medicine has again been awarded jointly, this time for miRNA discovery and its role in gene regulation

Discovery & Development Drug Discovery

Biopharmaceuticals: Simplifying Complexity With mRNA

| Gunasekaran Kannan | 7 min read

Here’s how an mRNA-based approach can overcome the development challenges of designing protein therapeutics.

Discovery & Development Dosage Forms

Dosage Form Innovation with Hot Melt Extrusion

| 3 min read

We look at three recent studies that demonstrate the versatility of hot melt extrusion for developing patient-centric dosage forms.

Discovery & Development Drug Discovery

Cell Wars: A New Hope

| Rob Coker

Researchers use AI to reprogram glioblastoma cancer cells

Discovery & Development Formulation

The Liquid Challenge

| Louise Carpenter | 4 min read

Regulators want more pediatric formulations. Companies often turn to liquids, but there are specific challenges that need to be considered.

Discovery & Development Clinical Trials

Clinical Trials and Digital Doubles

| 5 min read

Digital twins in clinical trials are changing how research is performed – but it won’t be a revolution, according to Phesi CEO Gen Li.

Discovery & Development Translational Science

Of Mice and Monkeys

| Rob Coker | 3 min read

The contribution of macaques to advancing human understanding of flu-like viruses, including H5N1, cannot be overstated.

Discovery & Development Clinical Trials

Inhibitors Versus Diabetes … And Dementia!

| Rob Coker

Research suggests diabetes patients using SGLT-2 and DPP-4 inhibitors have a decreased risk of developing dementia.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register